![[Trendlines in The Business Times] Trendlines sets up JV in Shanghai](https://blog.ourcrowd.com/wp-content/uploads/2017/08/logo-business-times.png){kind=logo}
The Trendlines Group on Monday announced that it has together with Chinese private equity firm Shoushan Wealth Holdings, set up China-Israel New Trend (Taizhou) Medical Technology. Read more on The Business Times...
Read MoreThe Trendlines Group Ltd. (OTCQX: TRNLY), Director of Investor Relations, Judith Kleinman was interviewed by OTC Markets Group (OTCQX: OTCM) in its OTCQX® Video Series. The series features one-on-one interviews with senior executives of OTCQX companies as they showcase their businesses and investment profiles. Read more on PR Newswire...
Read More![[Trendlines in Israel21c] Seedling startups reach full bloom in Israel’s incubators](https://blog.ourcrowd.com/wp-content/uploads/2017/01/israel21c-edited.jpg)
Shoham says Trendlines helped her build a professional team and is actively involved on a daily basis in focusing InPlant’s strategy and business development, referring potential partners and investors, advising on marcom and purchasing, and funding the legal work. Read more on Israel21c...
Read More![[Trendlines in The Times of Israel] Trendlines gets grant for urinary incontinence device](https://blog.ourcrowd.com/wp-content/uploads/2016/12/Times-of-Israel-Large.png)
Trendlines Labs is to receive a grant from the Singapore Israel Industrial Research and Development Foundation for the development and clinical trial of its stress urinary incontinence (SUI) product, which is being developed in partnership with the Singapore General Hospital. The 50 women in the trial, expected to start mid-2017 at the hospital, will provide feedback on the product. The foundation will provide up to 50 percent of the $400,000 the partners need to fund the final product development and clinical trial. Read more on The Times of Israel...
Read More
OurCrowd portfolio company The Trendlines Group was featured in The Times of Israel, an English-language news website covering Israel, the region & the Jewish world. The Trendlines Group establishes, invests in, and develops innovation-based medical and agritech businesses that improve the human condition. [T]op Singaporean investors and business officials, were in Israel to attend the annual company showcase of the Trendlines Group, which runs incubators for early-stage Israeli start-ups in the medical device and agriculture technology sectors. Displaying their wares before an audience of some 500 investors from Israel and around the world were Trendlines portfolio companies such as EdenShield, which is developing pesticides based on herbs and other natural ingredients, MiRobot, which is developing automated milking systems for farms, Steak TzarTzar, which is developing a grasshopper-based meat substitute, and others. The Trendlines Group raised $900,000 from OurCrowd investors in May 2013. Read more on the The Times of Israel...
Read More
